{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:26:40Z","timestamp":1740122800844,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T00:00:00Z","timestamp":1621382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T00:00:00Z","timestamp":1621382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute on Allergy and Infectious Diseases","doi-asserted-by":"crossref","award":["UM1AI068633, UM1AI068615, UM1AI106707"],"award-info":[{"award-number":["UM1AI068633, UM1AI068615, UM1AI106707"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s10461-021-03311-y","type":"journal-article","created":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T12:02:54Z","timestamp":1621425774000},"page":"3847-3857","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of Women\u2019s Home Environment on Use of the Dapivirine Vaginal Ring for HIV Prevention in Sub-Saharan Africa"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8499-154X","authenticated-orcid":false,"given":"Margaret W.","family":"Gichane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariana W. K.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Ngure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Scheckter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kubashni","family":"Woeber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishnaveni","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thelma","family":"Tauya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chifundo","family":"Zimba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliane","family":"Etima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nomvuyo","family":"Mangxilana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thesla","family":"Palanee-Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariane","family":"van der Straten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the MTN-025\/HOPE Study Team","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,19]]},"reference":[{"key":"3311_CR1","unstructured":"UNAIDS. We've got the power: Women, adolescent girls, and the HIV response. Geneva, Switzerland: UNAIDS; 2020."},{"issue":"e11","key":"3311_CR2","first-page":"0224898","volume":"14","author":"JB Griffin","year":"2019","unstructured":"Griffin JB, Ridgeway K, Montgomery E, Torjesen K, Clark R, Peterson J, et al. Vaginal ring acceptability and related preferences among women in low- and middle-income countries: A systematic review and narrative synthesis. PLoS One. 2019;14(e11):0224898.","journal-title":"PLoS One."},{"issue":"22","key":"3311_CR3","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1056\/NEJMoa1506110","volume":"375","author":"JM Baeten","year":"2016","unstructured":"Baeten JM, Palanee-Phillips T, Brown ER, Schwartz K, Soto-Torres LE, Govender V, et al. Use of a vaginal ring containing dapivirine for HIV-1 prevention in women. N Engl J Med. 2016;375(22):2121\u201332.","journal-title":"N Engl J Med"},{"key":"3311_CR4","unstructured":"Brown E, Palanee-Philips T, Marzinke M, Hendrix C, Dezutti C, Soto-Torres L, et al., editors. Residual dapivirine ring levels indicate higher adherence to vaginal ring is associated with HIV-1 protection. 21st International AIDS Society; 2016; Durban, South Africa."},{"issue":"22","key":"3311_CR5","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1056\/NEJMoa1602046","volume":"375","author":"A Nel","year":"2016","unstructured":"Nel A, van Niekerk N, Kapiga S, Bekker L-G, Gama C, Gill K, et al. Safety and efficacy of a dapivirine vaginal ring for HIV prevention in women. N Engl J Med. 2016;375(22):2133\u201343.","journal-title":"N Engl J Med"},{"key":"3311_CR6","unstructured":"Dapivirine Vaginal Ring 25 mg H-W-2168: Summary of Product Characteristics [press release]. 2020."},{"key":"3311_CR7","unstructured":"Baeten J, Palanee-Phillips T, Mgodi N, Ramjee G, Gati B, Mhlanga F, et al., editors. High adherence and sustained impact on HIV-1 incidence: Final results of an open-label extension trial of the dapivirine vaginal ring. 10th International AIDS Society Conference on HIV Science; 2019; Mexico City, Mexico."},{"key":"3311_CR8","unstructured":"Nel A, Malherbe M, Mans W, Van Baelen B, Van Niekerk N, Louw C, editors. Safety, adherence and HIV-1 seroconversion in DREAM\u2014an open-label dapivirine vaginal ring trial. 9th South African AIDS Conference; 2019."},{"key":"3311_CR9","unstructured":"Vaginal ring to reduce the risk of HIV infection for women in non-EU countries with high disease burden [press release]. 2020."},{"issue":"3","key":"3311_CR10","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1007\/s10461-019-02521-9","volume":"24","author":"E Pleasants","year":"2020","unstructured":"Pleasants E, Tauya T, Reddy K, Mirembe BG, Woeber K, Palanee-Phillips T, et al. Relationship type and use of the vaginal ring for HIV-1 prevention in the MTN 020\/ASPIRE trial. AIDS Behav. 2020;24(3):866\u201380.","journal-title":"AIDS Behav"},{"issue":"8","key":"3311_CR11","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1097\/QAD.0000000000001452","volume":"31","author":"ET Montgomery","year":"2017","unstructured":"Montgomery ET, van der Straten A, Chitukuta M, Reddy K, Woeber K, Atujuna M, et al. Acceptability and use of a dapivirine vaginal ring in a phase III trial. AIDS. 2017;31(8):1159\u201367.","journal-title":"AIDS"},{"issue":"3","key":"3311_CR12","doi-asserted-by":"crossref","first-page":"e25463","DOI":"10.1002\/jia2.25463","volume":"23","author":"J Velloza","year":"2020","unstructured":"Velloza J, Khoza N, Scorgie F, Chitukuta M, Mutero P, Mutiti K, et al. The influence of HIV-related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: a qualitative study. J Int AIDS S. 2020;23(3):e25463.","journal-title":"J Int AIDS S"},{"key":"3311_CR13","doi-asserted-by":"crossref","first-page":"19146","DOI":"10.7448\/IAS.17.3.19146","volume":"17","author":"A van der Straten","year":"2014","unstructured":"van der Straten A, Stadler J, Luecke E, Laborde N, Hartmann M, Montgomery ET, et al. Perspectives on use of oral and vaginal antiretrovirals for HIV prevention: the VOICE-C qualitative study in Johannesburg, South Africa. J Int AIDS Soc. 2014;17:19146.","journal-title":"J Int AIDS Soc"},{"key":"3311_CR14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2147\/IJWH.S185712","volume":"11","author":"MK Shapley-Quinn","year":"2019","unstructured":"Shapley-Quinn MK, Manenzhe KN, Agot K, Minnis AM, van der Straten A. \u201cWe are not the same\u201d: African women\u2019s view of multipurpose prevention products in the TRIO clinical study. Int J Womens Health. 2019;11:97\u2013107.","journal-title":"Int J Womens Health"},{"issue":"7","key":"3311_CR15","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1007\/s10461-020-02780-x","volume":"24","author":"CS Camlin","year":"2020","unstructured":"Camlin CS, Koss CA, Getahun M, Owino L, Itiakorit H, Akatukwasa C, et al. Understanding demand for PrEP and early experiences of PrEP use among young adults in rural Kenya and Uganda: a qualitative study. AIDS Behav. 2020;24(7):2149\u201362.","journal-title":"AIDS Behav"},{"issue":"2","key":"3311_CR16","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s11904-018-0385-0","volume":"15","author":"SA Golub","year":"2018","unstructured":"Golub SA. PrEP stigma: implicit and explicit drivers of disparity. Curr HIV\/AIDS Rep. 2018;15(2):190\u20137.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"11","key":"3311_CR17","doi-asserted-by":"publisher","first-page":"3692","DOI":"10.1007\/s10461-018-2195-1","volume":"22","author":"F Scorgie","year":"2018","unstructured":"Scorgie F, Stadler J, Baron D, Ju S, Ikaneng T, Mabude Z, et al. \u201cIt was not my aim to sleep there\u201d: the impact of timing and location of sex on adherence to coitally-dependent HIV pre-exposure prophylaxis. AIDS Behav. 2018;22(11):3692\u2013704.","journal-title":"AIDS Behav"},{"issue":"11","key":"3311_CR18","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1097\/QAD.0000000000001868","volume":"32","author":"ET Montgomery","year":"2018","unstructured":"Montgomery ET, Stadler J, Naidoo S, Katz AWK, Laborde N, Garcia M, et al. Reasons for nonadherence to the dapivirine vaginal ring: narrative explanations of objective drug-level results. AIDS. 2018;32(11):1517\u201325.","journal-title":"AIDS"},{"issue":"12","key":"3311_CR19","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.1007\/s10461-020-02910-5","volume":"24","author":"MW Gichane","year":"2020","unstructured":"Gichane MW, Moracco KE, Pettifor AE, Zimmer C, Maman S, Phanga T, et al. Socioeconomic predictors of transactional sex in a cohort of adolescent girls and young women in malawi: a longitudinal analysis. AIDS Behav. 2020;24(12):3376\u201384.","journal-title":"AIDS Behav"},{"issue":"2","key":"3311_CR20","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1016\/S2352-3018(20)30304-0","volume":"8","author":"JM Baeten","year":"2021","unstructured":"Baeten JM, Palanee-Phillips T, Mgodi NM, Mayo AJ, Szydlo DW, Ramjee G, et al. Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study. The Lancet HIV. 2021;8(2):e87\u201395.","journal-title":"The Lancet HIV"},{"key":"3311_CR21","unstructured":"van der Straten A, Katz A, Bal\u00e1n IC, Reddy K, Etima J, Woeber K, et al., editors. A Qualitative Evaluation of Women\u2019s Experience Receiving Drug Feedback in MTN-025\/HOPE-An HIV Prevention Open-Label Trial of the Dapivirine Vaginal Ring. 22nd International AIDS Conference; 2018; Amsterdam, Netherlands."},{"key":"3311_CR22","doi-asserted-by":"crossref","unstructured":"Guest G, MacQueen KM, Namey EE. Applied thematic analysis: sage publications; 2011.","DOI":"10.4135\/9781483384436"},{"issue":"3","key":"3311_CR23","doi-asserted-by":"publisher","first-page":"e25094","DOI":"10.1002\/jia2.25094","volume":"21","author":"A van der Straten","year":"2018","unstructured":"van der Straten A, Agot K, Ahmed K, Weinrib R, Browne EN, Manenzhe K, et al. The Tablets, Ring, Injections as Options (TRIO) study: what young African women chose and used for future HIV and pregnancy prevention. J Int AIDS Soc. 2018;21(3):e25094.","journal-title":"J Int AIDS Soc"},{"issue":"8","key":"3311_CR24","doi-asserted-by":"publisher","first-page":"e0135650","DOI":"10.1371\/journal.pone.0135650","volume":"10","author":"A Wondimu","year":"2015","unstructured":"Wondimu A, Molla F, Demeke B, Eticha T, Assen A, Abrha S, et al. Household Storage of Medicines and Associated Factors in Tigray Region, Northern Ethiopia. PLoS One. 2015;10(8):e0135650.","journal-title":"PLoS One."},{"issue":"1","key":"3311_CR25","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s12889-017-4152-8","volume":"17","author":"FS Teni","year":"2017","unstructured":"Teni FS, Surur AS, Belay A, Wondimsigegn D, Gelayee DA, Shewamene Z, et al. A household survey of medicine storage practices in Gondar town, northwestern Ethiopia. BMC Public Health. 2017;17(1):238.","journal-title":"BMC Public Health"},{"key":"3311_CR26","doi-asserted-by":"publisher","first-page":"21635","DOI":"10.7448\/IAS.20.5.21635","volume":"20","author":"S Nsanzimana","year":"2017","unstructured":"Nsanzimana S, Remera E, Ribakare M, Burns T, Dludlu S, Mills EJ, et al. Phased implementation of spaced clinic visits for stable HIV-positive patients in Rwanda to support Treat All. J Int AIDS Soc. 2017;20:21635.","journal-title":"J Int AIDS Soc"},{"issue":"5","key":"3311_CR27","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s10461-010-9806-9","volume":"15","author":"ET Montgomery","year":"2011","unstructured":"Montgomery ET, van der Straten A, Chidanyika A, Chipato T, Jaffar S, Padian N. The importance of male partner involvement for women\u2019s acceptability and adherence to female-initiated HIV prevention methods in Zimbabwe. AIDS Behav. 2011;15(5):959\u201369.","journal-title":"AIDS Behav"},{"key":"3311_CR28","first-page":"1","volume":"24","author":"ST Roberts","year":"2019","unstructured":"Roberts ST, Nair G, Baeten JM, Palanee-Philips T, Schwartz K, Reddy K, et al. Impact of male partner involvement on women\u2019s adherence to the dapivirine vaginal ring during a phase III HIV prevention trial. AIDS Behav. 2019;24:1\u201311.","journal-title":"AIDS Behav"},{"issue":"5","key":"3311_CR29","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s10461-016-1458-y","volume":"21","author":"KR Amico","year":"2017","unstructured":"Amico KR, Wallace M, Bekker L-G, Roux S, Atujuna M, Sebastian E, et al. Experiences with HPTN 067\/ADAPT study-provided open-label PrEP among women in cape town: facilitators and barriers within a mutuality framework. AIDS Behav. 2017;21(5):1361\u201375.","journal-title":"AIDS Behav"},{"issue":"11","key":"3311_CR30","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1080\/13691058.2018.1552989","volume":"21","author":"M Chitukuta","year":"2019","unstructured":"Chitukuta M, Duby Z, Katz A, Nakyanzi T, Reddy K, Palanee-Phillips T, et al. Negative rumours about a vaginal ring for HIV-1 prevention in sub-Saharan Africa. Cult Health Sex. 2019;21(11):1209\u201324.","journal-title":"Cult Health Sex"},{"key":"3311_CR31","first-page":"2021","volume-title":"Guidelines: updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoring","author":"World Health Organization","year":"2021","unstructured":"World Health Organization. Guidelines: updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoring. Geneva: World Health Organization; 2021. p. 2021."},{"issue":"5","key":"3311_CR32","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1188\/14.ONF.545-547","volume":"41","author":"N Carter","year":"2014","unstructured":"Carter N, Bryant-Lukosius D, DiCenso A, Blythe J, Neville AJ. The use of triangulation in qualitative research. Oncol Nurs Forum. 2014;41(5):545\u20137.","journal-title":"Oncol Nurs Forum"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-021-03311-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-021-03311-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-021-03311-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T04:41:28Z","timestamp":1725079288000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-021-03311-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,19]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3311"],"URL":"https:\/\/doi.org\/10.1007\/s10461-021-03311-y","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"type":"print","value":"1090-7165"},{"type":"electronic","value":"1573-3254"}],"subject":[],"published":{"date-parts":[[2021,5,19]]},"assertion":[{"value":"12 May 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was approved by the Institutional Review Boards at RTI International, and at each study site and regulated by the U.S. National Institutes of Health and the Microbicide Trials Network.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Written informed consent was obtained from all participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not Applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}